About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
Other PRICE INQUIRY no. JODO/19/PR68772/2024 – being conducted as a market assessment study22 November 2024In connection with the implementation of the project entitled “Development and introduction to the market of the first non-antibiotic product for the treatment of infectious… read more
Other PRICE INQUIRY no. NUSI/80/ZZ480370/2024 – being conducted as a market assessment study02 October 2024In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
Other PRICE INQUIRY no. NUSI/77/PR65652/2024 – being conducted as a market assessment study23 September 2024In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
Other PRICE INQUIRY no. NUSI/83/PR62534/2024 – being conducted as a market assessment study17 September 2024In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
Other PRICE INQUIRY no. RIA/9/PR57346/2024- being conducted as a market assessment study06 September 2024In connection with the implementation of the project titled „Design and development of an innovative solution – a complex, three-component medicinal product targeting the treatment… read more
